Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of a Phase I Study of Navitoclax in Patients With Relapsed or Refractory Disease von ROBERTS, Andrew W, SEYMOUR, John F, YUE CUI, BUSMAN, Todd A, MCKEEGAN, Evelyn M, KRIVOSHIK, Andrew P, ENSCHEDE, Sari H, HUMERICKHOUSE, Rod, BROWN, Jennifer R, WIERDA, William G, KIPPS, Thomas J, SEONG LIN KHAW, CARNEY, Dennis A, HE, Simon Z, HUANG, David C. S, HAO XIONG

Volltext

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL von Blombery, Piers, Lew, Thomas E., Dengler, Michael A., Thompson, Ella R., Lin, Victor S., Chen, Xiangting, Nguyen, Tamia, Panigrahi, Ashish, Handunnetti, Sasanka M., Carney, Dennis A., Westerman, David A., Tam, Constantine S., Adams, Jerry M., Wei, Andrew H., Huang, David C.S., Seymour, John F., Roberts, Andrew W., Anderson, Mary Ann

Volltext

ROS stress in cancer cells and therapeutic implications von Pelicano, Helene, Carney, Dennis, Huang, Peng

Volltext

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20+... von Roberts, Andrew W., Advani, Ranjana H., Kahl, Brad S., Persky, Daniel, Sweetenham, John W., Carney, Dennis A., Yang, Jianning, Busman, Todd B., Enschede, Sari H., Humerickhouse, Roderick A., Seymour, John F.

Volltext

Arsenic trioxide mechanisms of action - looking beyond acute promyelocytic leukemia von Carney, Dennis A.

Volltext

Detection of NPM1 exon 12 mutations and FLT3 - internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia von Tan, Angela Y C, Westerman, David A, Carney, Dennis A, Seymour, John F, Juneja, Surender, Dobrovic, Alexander

Volltext

Emergence of central nervous system myeloma in the era of novel agents von Gangatharan, Shane A, Carney, Dennis A, Prince, H Miles, Wolf, Max M, Januszewicz, E Henry, Ritchie, David S, Harrison, Simon J

Volltext

New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers von Wolyniec, Kamil, Carney, Dennis A, Haupt, Sue, Haupt, Ygal

Volltext

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features von Gill, Saar, Herbert, Kirsten E., Prince, H. Miles, Wolf, Max M., Wirth, Andrew, Ryan, Gail, Carney, Dennis A., Ritchie, David S., Davies, John M., Seymour, John F.

Volltext

OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action von Zhou, Yan, Garcia-Prieto, Celia, Carney, Dennis A., Xu, Rui-hua, Pelicano, Helene, Kang, Ying, Yu, Wensheng, Lou, Changgang, Kondo, Seiji, Liu, Jinsong, Harris, David M., Estrov, Zeev, Keating, Michael J., Jin, Zhendong, Huang, Peng

Volltext

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy von Cheah, Chan Y., Dickinson, Michael, Hofman, Michael S., George, Anupkumar, Ritchie, David S., Prince, H. Miles, Westerman, David, Harrison, Simon J., Burbury, Kate, Wolf, Max, Januszewicz, Henry, Herbert, Kirsten E., Carney, Dennis A., Tam, Constantine, Seymour, John F.

Volltext

All is not lost - the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab von Cheah, Chan Y., Lew, Thomas E., Lee, Rebecca, Tam, Constantine S., Seymour, John F., Carney, Dennis A.

Volltext

Cytogenetic response is not a prerequisite for clinical response in patients with myelodysplastic syndromes treated with azacitidine von Gangatharan, Shane A., Carney, Dennis A., Campbell, Lynda J., Prince, H. Miles, Kenealy, Melita K., Seymour, John F.

Volltext

Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein A clinicopathologic study of 26 cases von CAMERON YIN, C, PEI LIN, CARNEY, Dennis A, HANDY, Beverly C, RASSIDAKIS, George Z, ADMIRAND, Joan H, KEATING, Michael J, MEDEIROS, L. Jeffrey

Volltext

1.30 Caspase 10 is Down-Regulated in Chronic Lymphocytic Leukemia von Mikeska, Thomas, Essakali, Salim, Hewitt, Chelsee A, Carney, Dennis A, Westerman, David, Seymour, John F, Dobrovic, Alexander

Volltext

1.21 Clinical and Molecular-Pathological Characteristics of Richter's Syndrome von Davis, Ian, Dickinson, Michael, Lee, Rebecca, Wong, Stephen, Westerman, David A, Seymour, John F, Carney, Dennis A

Volltext

4.33 Characteristics and Outcome of CLL Relapse Post-Fludarabine, Cyclophosphamide ± Rituximab von Carney, Dennis A, Lee, Rebecca, Hewitt, Chelsea, Ritchie, David S, Westerman, David A, Seymour, John F

Volltext

Shielding the Vulnerable: A Multicentre Australian Rollout of Evusheld to Patients with Chronic Lymphocytic Leukaemia (CLL-SHIELD) von Whitechurch, Ashley, Bennett, Rory, Inam, Shafqat, Hartog, Benjamin, Blackwood, Rebecca, Fernando, Shevon, Hutani, Felanita, Bortz, Hadley, Lincoln, Mitchel, Carney, Dennis, Roberts, Andrew W, Anderson, Mary Ann, Tam, Constantine S., Seymour, John F.

Volltext

Long Term Outcomes of Venetoclax Therapy for Complex Karyotype Relapsed/Refractory Chronic Lymphocytic Leukemia von Lew, Thomas, Anderson, Mary Ann, Tam, Constantine S., Handunnetti, Sasanka, Carney, Dennis, Wall, Meaghan, Roberts, Andrew W., Seymour, John F.

Volltext

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results von Seymour, John F, Roberts, Andrew W, Carney, Dennis A, Dyer, Martin J.S, Kipps, Thomas J, Hallek, Michael, Bociek, R. Gregory, Brown, Jennifer R, Wierda, William G, Rai, Kanti, Ribeiro de Oliveira, Moacyr, McKeegan, Evelyn, Chyla, Brenda, Busman, Todd, Krivoshik, Andrew, Enschede, Sari, Humerickhouse, Rod

Volltext